even if new information becomes available in the future. SHARE THIS POST Iterum Therapeutics NewsMORE your MARKET VIEW Related Stocks Find News …
Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection
Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection
Leave a reply